Dendritic cell cancer and effects: Dendritic cell therapy in breast cancer tumors of advanced breast cancer shows promising results. The 3-year survival ranges from 1% to 16% from time of initiation of dendritic cell therapy. Study which was contributed by Yahoo Prof. Robert Gorter

  • Dendritic cell cancer and effects: Dendritic cell therapy in breast cancer tumors of advanced breast cancer shows promising results. The 3-year survival ranges from 1% to 16% from time of initiation of dendritic cell therapy. Study which was contributed by Yahoo Prof. Robert Gorter